Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
The all-in-one diagnostic platform combines hematology, biochemistry, and immunoassay testing in a single run.
BD has added three- and four-laser versions of its FACSDiscover A8 analyzer, offering additional configuration choices for labs using spectral flow cytometry.
The system is designed to handle more than 10,000 injections without cleaning and scan over 900 SRM transitions per second for high-throughput laboratories.
The qPCR-based test detects variants that increase risk of severe fluoropyrimidine chemotherapy toxicity.
Hospital teams can trial the company's BSI/AMR test and preview the LiDia-SEQ system ahead of commercial launch.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.